Press release


Munich (DE) & Antwerp (BE), 20 November 2024, 07:45 CET



Gimv sells to Fremman Capital a majority stake in outpatient
rehabilitation specialist rehaneo
rehaneo, a leading provider of outpatient rehabilitation, aftercare, prevention, and
occupational health management founded in 2020, welcomes Fremman Capital
to its shareholder base. Fremman takes over the majority shareholding previously
held by the European investment company Gimv. Founder and CEO Bruno Crone
and co-founder and COO Christoph Dühr remain significantly invested in the
company and continue their management roles.

Since its founding four years ago, during the increasing demand from patients who want to
peak of the COVID-19 pandemic, Gimv and stay in their familiar environment during
the managing rehaneo shareholders Bruno rehabilitation. Together with Fremman, the
Crone and Christoph Dühr have successfully management team intends to continue the
built the company into one of the top three successful growth strategy, accelerating M&A
providers in the field of outpatient rehabilitation and consolidating further a very fragmented
through a successful buy-and-build strategy. sector, to create a European leader.
Since 2023, Dr. Alain Robbe-Grillet completes
the management team as CFO. Bruno Crone, Founder and CEO of the rehaneo
group, declares: “We thank Gimv for their
To date, rehaneo has integrated 13 companies active support and the trustful cooperation
at 23 locations nationwide into the group, from the beginning, which made it possible to
including some of the leading facilities in become one of the leading quality providers in
Germany. Recently, rehaneo also opened a outpatient rehabilitation in such a short time.
completely new center in Göttingen. We are excited to start a new chapter of our
success story with Fremman. Our focus will be
The rehaneo group now employs over 1,000 on acquiring new outpatient rehab centers
staff who are dedicated to the care of more and the strategic development of existing
than 80,000 patients and customers annually. facilities and the entire group.”
The range of services offered by the centers
varies by location, from outpatient Mirko Meyer-Schönherr and Max
rehabilitation and rehab aftercare to Schürenkrämer, Founding Partner and
physiotherapy and occupational therapy, as Managing Director at Fremman, add: “We are
well as prevention and fitness. In addition to very impressed by the development of the
developing locations and the continuous rehaneo group so far and see great potential
growth of the group, the focus is primarily on in the outpatient rehabilitation sector. We look
the quality of services. This is ensured, among forward to supporting the experienced and
other things, by a medical board with ambitious rehaneo management team in
renowned experts, including Prof. Dr. med. further developing the strategy of the group.”
Thomas Wessinghage. rehaneo aims to further
densify the care network and offer more Philipp von Hammerstein and Lars Timmer,
people professional rehabilitation close to their Partner and Principal at Gimv Healthcare,
homes. comment: “We are proud that together with
rehaneo, we have built a leading company
Outpatient rehabilitation costs are significantly and competent partner in outpatient care in
lower than inpatient stays, benefiting the just four years, distinguished by high customer
healthcare system. Additionally, there is and patient satisfaction as well as high-quality
standards.”




Gimv NV - Karel Oomsstraat 37, 2018 Antwerp, Belgium - T +32 3 290 21 00 - www.gimv.com 1
Munich (DE) & Antwerp (BE), 20 November 2024, 07:45 CET

Press release



The transaction is subject to approval by the
German antitrust authorities and is expected to About Gimv
close in Q1 2025. This transaction will have a
positive impact on our NAV at 30 September Gimv is a European investment company, listed
2024, as will be published on 21 November next, on Euronext Brussels and a member of the
of around EUR 1 per share. The realized return Euronext BEL ESG Index. With over 40 years'
on this transaction substantially exceeds our experience in private equity, Gimv currently has
long-term portfolio return target. an investment portfolio of more than EUR 1.5
billion. The portfolio contains around 60 portfolio
companies, with combined turnover of EUR 4.0
billion and more than 20,000 employees.

As a recognized market leader in selected
investment platforms, Gimv identifies
entrepreneurial, innovative companies with high
growth potential and supports them in their
transformation into market leaders. Gimv's five
investment platforms are Consumer, Healthcare,
Life Sciences, Smart Industries and Sustainable
Cities. Each platform works with an experienced
team across Gimv’s home markets of Benelux,
France and DACH, supported by an extended
international network of experts.

Further information on Gimv can be found on
www.gimv.com.

For further information please contact:

Bart Diels, Managing Partner - Head of Healthcare
T +32 +32 3 290 21 58
bart.diels@gimv.com

Philip von Hammerstein, Partner Healthcare
T +49 89 44 23 275 10
philipp.vonhammerstein@gimv.com




Gimv NV - Karel Oomsstraat 37, 2018 Antwerp, Belgium - T +32 3 290 21 00 - www.gimv.com 2